MMP2 and breast carcinoma: Furthermore, CBD restrict epidermal growth factor (EGF)-induced tumorigenic properties by inhibiting EGFR, Akt, ERK, and NF-κB signaling pathways as well as matrix metalloproteinase 2 and 9 in human breast cancer cells [76].